drugset / Trial / NCT01650155
Single Rising Dose Study With Intravenous Infusion and Subcutaneous Injection of BI 1005273 in Healthy Male Volunteers.
RandomizedSingle-groupSingle-blindTreatment
Summary
To investigate the safety and tolerability of BI 1005273 in healthy male volunteers following intravenous (i.v.) infusion of single rising doses and subcutaneous (s.c.) injection. Secondary objectives are the exploration of the pharmacokinetics and early pharmacodynamics of BI 1005273.
Timeline
- Start
- 2012-07
- Primary completion
- 2014-09
- Completion
- 2014-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 1005273 | Unknown | — | Subcutaneous |
| Subject | BI 1005273 | Unknown | — | Intravenous |
Indications
No indication recorded.